Loading...
Immunoglobulin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Immunoglobulin
2025-Q4
Comprehensive analysis of India’s immunoglobulin export trade — suppliers, buyers, prices, routes, and every shipment record.
37
Shipments
$4.82M
Trade Value
11
Suppliers
25
Buyers
22
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/immunoglobulin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s immunoglobulin trade — 2025-Q4
KEY TAKEAWAY
Immunoglobulin 2025-Q4 exports total $4.8M across 22 countries, with RELIANCE LIFE SCIENCES PVT LTD commanding 86.6% market share.
TOTAL SHIPMENTS
37
2025-Q4
EXPORT VALUE
$4.8M
FOB USD
TOTAL QUANTITY
58.9K
units shipped
INDIAN SUPPLIERS
11
unique exporters
GLOBAL BUYERS
25
unique importers
DESTINATIONS
22
countries
MEDIAN UNIT PRICE
$109.61
per unit
TOP-5 SHARE
99.6%
of total USD
BRANDED SHARE
78.4%
29 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
RELIANCE LIFE SCIENCES PVT LTD is India's #1 Immunoglobulin exporter with $4.2M (86.6% market share).→ §5, Indian Supplier Rankings
2
Immunoglobulin reached 22 countries, with Sri Lanka as the top destination ($2.2M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 7587) — top 10 suppliers control 100.0% of exports.→ §5, Indian Supplier Rankings
4
100.0% of buyers (25 of 25) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Vial dominates (44.8%) across 5 dosage forms.→ §7, Price Benchmarks
6
22 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 RELIANCE LIFE SCIENCES PVT LTD leads in volume — how do 11 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian immunoglobulin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Immunoglobulin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial immunoglobulin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian immunoglobulin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Immunoglobulin India trade report
Product scope
Immunoglobulin
All variants merged — branded and generic formulations of immunoglobulin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
37
Every commercial immunoglobulin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $181.7K, Nov $3.9M, Dec $690.8K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$181.7K
Oct USD
2 shipments
2
$3.9M
Nov USD
+2071.4% MoM
3
$690.8K
Dec USD
-82.5% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 2071.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $182K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $4.8M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $3.8M rise in Nov, $3.3M decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $182K | 2 shipments |
| Nov | $3.9M | 24 shipments |
| Dec | $691K | 11 shipments |
| Q4 Total | $4.8M | 37 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Sri Lanka held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: RELIANCE LIFE SCIENCES PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import immunoglobulin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Sri Lanka absorbs 45.1% of India’s 2025-Q4 immunoglobulin trade ($2.2M). Beyond the top 10 destinations, 22 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 8 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 22 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much immunoglobulin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$3.8M
79.0% of trade
8 countries · 19 shipments
Europe
$56K
1.2% of trade
3 countries · 3 shipments
Americas
$606K
12.6% of trade
3 countries · 4 shipments
Africa
$348K
7.2% of trade
8 countries · 11 shipments
Fig 4.1 Sri Lanka is the #1 corridor ($2.2M) — 22 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian immunoglobulin it receives (light = low, dark = high). Orange arcs radiate from India to the top 22 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sri Lanka | $2.2M | 2 | RELIANCE LIFE SCIENCES PVT LTD | $2.2M | — | — | — | — |
| 2 | Philippines | $861K | 6 | RELIANCE LIFE SCIENCES PVT LTD | $655K | BHARAT SERUMS AND VACCINES LTD | $206K | — | — |
| 3 | Lebanon | $545K | 2 | RELIANCE LIFE SCIENCES PVT LTD | $545K | — | — | — | — |
| 4 | Colombia | $410K | 2 | RELIANCE LIFE SCIENCES PVT LTD | $410K | — | — | — | — |
| 5 | Nicaragua | $182K | 1 | CAPLIN POINT LABORATORIES LTD | $182K | — | — | — | — |
| 6 | Vietnam | $138K | 2 | RELIANCE LIFE SCIENCES PVT LTD | $138K | — | — | — | — |
| 7 | Kenya | $134K | 2 | RELIANCE LIFE SCIENCES PVT LTD | $127K | M T MADON EXPORTS | $8K | — | — |
| 8 | Tanzania | $96K | 1 | BHARAT SERUMS AND VACCINES LTD | $96K | — | — | — | — |
| 9 | Bahrain | $89K | 1 | RELIANCE LIFE SCIENCES PVT LTD | $89K | — | — | — | — |
| 10 | Uganda | $47K | 2 | BHARAT SERUMS AND VACCINES LTD | $47K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 79.0% of USD — but Sri Lanka is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
45.1%
#1 country share
Sri Lanka alone
86.6%
Top 5 share
5 of 22 countries
99.5%
Top 15 share
Long tail of 7 countries = 0.5%
HHI 2597
Destination HHI
Highly concentrated
22
Countries served
Global pharma reach from India
8
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
11 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
RELIANCE LIFE SCIENCES PVT LTD ($4.2M, 86.6% share) and BHARAT SERUMS AND VACCINES LTD ($392.7K) together control 94.8% of India’s 2025-Q4 immunoglobulin trade. The top 5 suppliers hold 99.6%. 11 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian immunoglobulin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 RELIANCE LIFE SCIENCES PVT LTD leads by $3.8M over BHARAT SERUMS AND VACCINES LTD — top 11 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MEDICARE PHARMA is #11 by value but #3 by volume.
Fig 5.2 RELIANCE LIFE SCIENCES PVT LTD also leads by shipment count (19) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MEDICARE PHARMA moves from #3 by volume to #11 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 11 immunoglobulin suppliers split into strategic segments
KEY TAKEAWAY
3 suppliers (25%) generate 98.5% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 RELIANCE LIFE SCIENCES PVT LTD and BHARAT SERUMS AND VACCINES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 98.5% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PVT LTD | 4 | 10 | $4.2M |
| 2 | BHARAT SERUMS AND VACCINES LTD | 3 | 5 | $393K |
| 3 | CAPLIN POINT LABORATORIES LTD | 1 | 1 | $182K |
| 4 | GLENMARK PHARMACEUTICALS LTD | 1 | 1 | $37K |
| 5 | VAMA LIFECARE PVT LTD | 1 | 1 | $15K |
| 6 | M T MADON EXPORTS | 1 | 1 | $8K |
| 7 | WELLKIND PHARMACEUTICAL PVT LTD | 1 | 1 | $5K |
| 8 | GOOD FAITH PHARMA IMPEX | 1 | 1 | $4K |
| 9 | KHATU ENTERPRISES | 1 | 1 | $691 |
| 10 | CHARAK PHARMA PVT LTD | 1 | 1 | $145 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the immunoglobulin manufacturing hubs
KEY TAKEAWAY
Thane Belapur Rd Rabale Navi Mumbai and Navi Mumbai Maharashtra together account for $4.2M of India’s 2025-Q4 immunoglobulin trade.
Fig 5.5 Thane Belapur Rd Rabale Navi Mumbai (1 exporters, $2.8M) and Navi Mumbai Maharashtra (1 exporters, $1.4M) are India’s immunoglobulin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
99.6%
Top 5 share
5 of 11 suppliers
100.0%
Top 10 share
10 of 11 suppliers
98.5%
Top 25% share
3 suppliers = 99% USD
HHI 7587
Supplier HHI
Concentrated
11
Total suppliers
shipped Immunoglobulin in 2025-Q4
11+ cities
Indian hubs
Thane Belapur Rd Rabale Navi Mumbai and Navi Mumbai Maharashtra lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | RELIANCE LIFE SCIENCES PVT LTD | $4.2M |
| #2 | BHARAT SERUMS AND VACCINES LTD | $393K |
#1
EXPORTER PROFILE #1 OF 2
RELIANCE LIFE SCIENCES PVT LTD
Navi Mumbai Maharashtra · India’s #1 immunoglobulin supplier by USD · 2025-Q4
2025-Q4 USD
$4.2M
86.6% market share
SHIPMENTS
19
avg $220K/ship
COUNTRIES
10
destination markets
BUYERS
11
11 single-sourced
BRANDED
84%
of shipments
DOSAGE FORMS
4
product types
TOP 10 DESTINATIONS
Sri Lanka is the #1 market at $2.2M (52% of trade), followed by Philippines at $655K. 10 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sri Lanka | $2.2M | 2 | 52.1% |
| 2 | Philippines | $655K | 5 | 15.7% |
| 3 | Lebanon | $545K | 2 | 13.1% |
| 4 | Colombia | $410K | 2 | 9.8% |
| 5 | Vietnam | $138K | 2 | 3.3% |
| 6 | Kenya | $127K | 1 | 3.0% |
| 7 | Bahrain | $89K | 1 | 2.1% |
| 8 | Zimbabwe | $24K | 1 | 0.6% |
| 9 | Rwanda | $12K | 1 | 0.3% |
| 10 | Myanmar | $0 | 2 | 0.0% |
MONTHLY TREND
Nov peaked at $3.5M. Oct was the weakest at $0.
PRODUCT MIX
Vial dominates at 52% of trade. Solution (30.7%) and Other are secondary formulations.
TOP BUYERS · 11/11 LOCKED IN
11 of 11 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| STATE PHARMACEUTICALS … | Sri Lanka | $2.2M | ⚠ Locked |
| AMBICA INTERNATIONAL C… | Philippines | $655K | ⚠ Locked |
| LEVANT PULSE | Lebanon | $545K | ⚠ Locked |
| NEXT PHARMA SOURCING SAS | Colombia | $410K | ⚠ Locked |
| DUY ANH TRADING PHARMA… | Vietnam | $138K | ⚠ Locked |
| GALAXY PHARMACEUTICAL … | Kenya | $127K | ⚠ Locked |
| GULF PHARMACIES W.L.L | Bahrain | $89K | ⚠ Locked |
| WMT PHARMACEUTICALS PV… | Zimbabwe | $24K | ⚠ Locked |
| ABC PHARMA SERVICES (P… | Sri Lanka | $17K | ⚠ Locked |
| STAR BIOTECH LTD | Rwanda | $12K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
RELIANCE LIFE SCIENCES PVT LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Sri Lanka absorbs $2.2M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#2
EXPORTER PROFILE #2 OF 2
BHARAT SERUMS AND VACCINES LTD
Airoli Navi Mumbai · India’s #2 immunoglobulin supplier by USD · 2025-Q4
2025-Q4 USD
$393K
8.1% market share
SHIPMENTS
6
avg $65K/ship
COUNTRIES
5
destination markets
BUYERS
5
5 single-sourced
BRANDED
50%
of shipments
DOSAGE FORMS
3
product types
TOP 5 DESTINATIONS
Philippines is the #1 market at $206K (52% of trade), followed by Tanzania at $96K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Philippines | $206K | 1 | 52.5% |
| 2 | Tanzania | $96K | 1 | 24.4% |
| 3 | Uganda | $47K | 2 | 12.0% |
| 4 | Mauritius | $28K | 1 | 7.2% |
| 5 | France | $15K | 1 | 3.9% |
MONTHLY TREND
Nov peaked at $369K. Oct was the weakest at $0.
PRODUCT MIX
Other dominates at 52% of trade. Solution (41.5%) and Injection are secondary formulations.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| BSV BIOSCIENCE PHILIPP… | Philippines | $206K | ⚠ Locked |
| GENERICS & SPECIALITIE… | Tanzania | $96K | ⚠ Locked |
| ABACUS PHARMA (A) LTD | Uganda | $47K | ⚠ Locked |
| IBL LTD | Mauritius | $28K | ⚠ Locked |
| TEDIS | France | $15K | ⚠ Locked |
#2
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
BHARAT SERUMS AND VACCINES LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 Philippines absorbs $206K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
25 importers across 22 countries — who is buying Indian immunoglobulin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 100.0% of total USD. 100% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian immunoglobulin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 STATE PHARMACEUTICALS CORP is the #1 importer at $2.2M (44.8%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
100%
Single-source
25 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
0%
Broad-source (5+)
0 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source immunoglobulin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| STATE PHARMACEUTICALS … | RELIANCE LIFE SCIENC… | $2.2M | $97.321 | Vial |
| ABC PHARMA SERVICES (P… | RELIANCE LIFE SCIENC… | $17K | $173.816 | Solution |
Philippines 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AMBICA INTERNATIONAL C… | RELIANCE LIFE SCIENC… | $655K | $40.906 | Other |
| BSV BIOSCIENCE PHILIPP… | BHARAT SERUMS AND VA… | $206K | $206.013 | Other |
Kenya 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| GALAXY PHARMACEUTICAL … | RELIANCE LIFE SCIENC… | $127K | $101.442 | Solution |
| MORAN PHARMACY LTD | M T MADON EXPORTS | $8K | $76.040 | Injection |
Lebanon 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| LEVANT PULSE | RELIANCE LIFE SCIENC… | $545K | $129.852 | Solution |
Colombia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NEXT PHARMA SOURCING SAS | RELIANCE LIFE SCIENC… | $410K | $114.773 | Solution |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | STATE PHARMACEUTICAL… | Sri Lanka | $2.2M | $2.2M | Premium |
| 2 | AMBICA INTERNATIONAL… | Philippines | $655K | $131K | Premium |
| 3 | LEVANT PULSE | Lebanon | $545K | $273K | Premium |
| 4 | NEXT PHARMA SOURCING… | Colombia | $410K | $205K | Premium |
| 5 | BSV BIOSCIENCE PHILI… | Philippines | $206K | $206K | Premium |
| 6 | NEOETHICALS, S.A | Nicaragua | $182K | $182K | Premium |
| 7 | DUY ANH TRADING PHAR… | Vietnam | $138K | $69K | Premium |
| 8 | GALAXY PHARMACEUTICA… | Kenya | $127K | $127K | Premium |
| 9 | GENERICS & SPECIALIT… | Tanzania | $96K | $96K | Premium |
| 10 | GULF PHARMACIES W.L.L | Bahrain | $89K | $89K | Premium |
| 11 | ABACUS PHARMA (A) LTD | Uganda | $47K | $24K | Mid |
| 12 | DIFA COOPER S.P.A | Italy | $37K | $37K | Premium |
| 13 | IBL LTD | Mauritius | $28K | $28K | Mid |
| 14 | WMT PHARMACEUTICALS … | Zimbabwe | $24K | $24K | Mid |
| 15 | ABC PHARMA SERVICES … | Sri Lanka | $17K | $17K | Mid |
| 16 | TEDIS | France | $15K | $15K | Mid |
| 17 | AS PER INVOICE BRAZIL | Brazil | $15K | $15K | Mid |
| 18 | STAR BIOTECH LTD | Rwanda | $12K | $12K | Budget |
| 19 | MORAN PHARMACY LTD | Kenya | $8K | $8K | Budget |
| 20 | NEW AFRICA SOFTWARE … | Ghana | $5K | $5K | Budget |
| 21 | LYUDMIL STANEV | Bulgaria | $4K | $4K | Budget |
| 22 | HORIZON PHARMACEUTIC… | Somalia | $691.148 | $346.000 | Budget |
| 23 | ALPINE PHARMA.DISTT … | Nepal | $145.094 | $145.000 | Budget |
| 24 | TREE TOP HEALTH PVT … | Maldives | $8.512 | $3.000 | Budget |
| 25 | ASIA HEALTH & WEALTH… | Myanmar | $0.0000 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 11 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 RELIANCE LIFE SCIENCES PVT LTD → STATE PHARMACEUTICALS CORP is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 11 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian immunoglobulin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Immunoglobulin prices span 13007× ($0.020 → $257.46). The coefficient of variation is 0.70. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.020 | Lowest observed unit price |
| P5 | $0.062 | 5th percentile |
| P25 | $64.57 | 25th percentile (Q1) |
| Median | $109.61 | 50th percentile (Q2) |
| P75 | $135.69 | 75th percentile (Q3) |
| P95 | $224.42 | 95th percentile |
| Max | $257.46 | Highest observed unit price |
| Mean | $101.85 | Arithmetic average |
| CV | 70% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 GOOD FAITH PHARMA IMPEX prices at $246.91/unit vs market median $109.61.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. GLENMARK PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. RELIANCE LIFE SCIENCES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | BHARAT SERUMS AN… | Mauritius | Solution | 110 | $28K | $257.46 | Specialty / small-batch |
| Nov 2025 | GOOD FAITH PHARM… | Bulgaria | Other | 15 | $4K | $246.91 | Specialty / small-batch |
| Nov 2025 | BHARAT SERUMS AN… | Philippines | Other | 1K | $206K | $206.01 | Specialty / small-batch |
| Nov 2025 | BHARAT SERUMS AN… | Tanzania | Solution | 500 | $96K | $191.66 | Specialty / small-batch |
| Dec 2025 | RELIANCE LIFE SC… | Sri Lanka | Solution | 100 | $17K | $173.82 | Specialty / small-batch |
| Nov 2025 | WELLKIND PHARMAC… | Ghana | Injection | 30 | $5K | $169.69 | Sterile formulation premium |
| Dec 2025 | RELIANCE LIFE SC… | Bahrain | Injection | 550 | $89K | $161.45 | Sterile formulation premium |
| Nov 2025 | BHARAT SERUMS AN… | France | Solution | 100 | $15K | $153.21 | Specialty / small-batch |
| Nov 2025 | RELIANCE LIFE SC… | Lebanon | Solution | 2K | $195K | $129.85 | Specialty / small-batch |
| Nov 2025 | RELIANCE LIFE SC… | Lebanon | Solution | 3K | $351K | $129.85 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | MEDICARE PHARMA | Maldives | Tablet | 100 | $1.98 | $0.020 | Small sample / trial shipment |
| Nov 2025 | MEDICARE PHARMA | Maldives | Tablet | 40 | $1.19 | $0.030 | Small sample / trial shipment |
| Nov 2025 | MEDICARE PHARMA | Maldives | Tablet | 60 | $5.34 | $0.089 | Small sample / trial shipment |
| Oct 2025 | CHARAK PHARMA PV… | Nepal | Solution | 180 | $145.09 | $0.806 | Small sample / trial shipment |
| Dec 2025 | RELIANCE LIFE SC… | Philippines | Solution | 5K | $8K | $1.47 | Specialty / small-batch |
| Dec 2025 | RELIANCE LIFE SC… | Philippines | Solution | 625 | $921.73 | $1.47 | Specialty / small-batch |
| Nov 2025 | GLENMARK PHARMAC… | Italy | Other | 4K | $37K | $9.58 | Specialty / small-batch |
| Nov 2025 | RELIANCE LIFE SC… | Philippines | Other | 1K | $79K | $64.57 | Specialty / small-batch |
| Nov 2025 | RELIANCE LIFE SC… | Philippines | Other | 9K | $567K | $64.57 | Specialty / small-batch |
| Nov 2025 | RELIANCE LIFE SC… | Vietnam | Solution | 2K | $138K | $66.95 | Specialty / small-batch |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship immunoglobulin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Immunoglobulin leaves India through 3+ ports. The top 5 (MUMBAI AIR (SAHAR), CHENNAI AIR, RAXAUL) handle 100.0% of total USD. AIR moves 95% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $2.5M — top 3 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 COLOMBO is the #1 global destination port — top 22 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 95% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$4.8M
100.0% of USD · 94.6% of ships
SEA
$922
0.0% of USD · 2.7% of ships
ROAD
$145
0.0% of USD · 2.7% of ships
Fig 8.3 The dominant corridor is CHENNAI AIR → Air → Asia ($2.2M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Maldives is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 8933).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Maldives (HHI 10,000) is the most concentrated — Philippines (HHI 6,358) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 19 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| STATE PHARMACEUTICAL… | Sri Lanka | RELIANCE LIFE SC… | $2.2M | 1 | CRITICAL |
| AMBICA INTERNATIONAL… | Philippines | RELIANCE LIFE SC… | $655K | 5 | CRITICAL |
| LEVANT PULSE | Lebanon | RELIANCE LIFE SC… | $545K | 2 | CRITICAL |
| NEXT PHARMA SOURCING… | Colombia | RELIANCE LIFE SC… | $410K | 2 | HIGH |
| BSV BIOSCIENCE PHILI… | Philippines | BHARAT SERUMS AN… | $206K | 1 | HIGH |
| NEOETHICALS, S.A | Nicaragua | CAPLIN POINT LAB… | $182K | 1 | HIGH |
| DUY ANH TRADING PHAR… | Vietnam | RELIANCE LIFE SC… | $138K | 2 | HIGH |
| GALAXY PHARMACEUTICA… | Kenya | RELIANCE LIFE SC… | $127K | 1 | HIGH |
Conclusion: 25 buyers depend on exactly one Indian supplier, representing $4.8M in trade. 3 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Colombia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nicaragua | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Vietnam | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Bahrain | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Uganda | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Italy | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mauritius | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zimbabwe | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Sri Lanka | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Maldives lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Sri Lanka (1 suppliers) | This Q | HIGH |
| A6 | Enter Philippines (2 suppliers) | This Q | MED |
| A8 | Build Philippines distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Sri Lanka tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Sri Lanka | Asia | 1 | $2.2M | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Philippines | Asia | 2 | $861K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Lebanon | Other | 1 | $545K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Colombia | Other | 1 | $410K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Nicaragua | Other | 1 | $182K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Vietnam | Asia | 1 | $138K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Kenya | Africa | 2 | $134K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Tanzania | Africa | 1 | $96K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Bahrain | Other | 1 | $89K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Uganda | Africa | 1 | $47K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Italy | Other | 1 | $37K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Mauritius | Africa | 1 | $28K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Zimbabwe | Africa | 1 | $24K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | France | Other | 1 | $15K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Brazil | Other | 1 | $15K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 37 2025-Q4 Immunoglobulin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/immunoglobulin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 37 2025-Q4 immunoglobulin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian immunoglobulin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
37
across all regions
TOTAL USD
$4.82M
2025-Q4 FOB value
UNITS
58.9K
tablets, capsules, etc.
SUPPLIERS
11
Indian exporters
BUYERS
25
global importers
COUNTRIES
22
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $348K (7.2%), spanning 8 countries.
11 Indian suppliers shipped to 25 buyers across 22 countries — average shipment value $130K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
8 countries · 11 shipments · $348K · 5 Indian suppliers · 9 buyers
SHIPMENTS
11
USD
$348K
COUNTRIES
8
SUPPLIERS
5
BUYERS
9
HHI
4,632
concentrated
Top 8 destination countries in Africa
1
Kenya (38.7%)
$134K
2
Tanzania (27.6%)
$96K
3
Uganda (13.6%)
$47K
4
Mauritius (8.1%)
$28K
5
Zimbabwe (6.9%)
$24K
6
Rwanda (3.5%)
$12K
7
Ghana (1.5%)
$5K
8
Somalia (0.2%)
$691.15
Top 5 Indian suppliers into Africa
1
BHARAT SERUMS AND VACCINES LTD
$171K
2
RELIANCE LIFE SCIENCES PVT LTD
$163K
3
M T MADON EXPORTS
$8K
4
WELLKIND PHARMACEUTICAL PVT LTD
$5K
5
KHATU ENTERPRISES
$691.15
Top 9 Africa importers
1
GALAXY PHARMACEUTICAL LTD · Kenya
$127K
2
GENERICS & SPECIALITIES LTD · Tanzania
$96K
3
ABACUS PHARMA (A) LTD · Uganda
$47K
4
IBL LTD · Mauritius
$28K
5
WMT PHARMACEUTICALS PVT LTD · Zimbabwe
$24K
6
STAR BIOTECH LTD · Rwanda
$12K
7
MORAN PHARMACY LTD · Kenya
$8K
8
NEW AFRICA SOFTWARE SOLUTION LTD · Ghana
$5K
9
HORIZON PHARMACEUTICAL COMPANY · Somalia
$691.15
Top 2 dosage forms
1
Solution
$311K
2
Injection
$37K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 7 | $197K | $28K |
| Dec | 4 | $151K | $38K |
Shipment register · 11 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BHARAT SERUMS AND VACCINES LTD · 4 shipments · $171K | |||||||||||
| 1 | Nov 2025 | ABACUS PHARMA (A) LTD | Uganda | Solution | 200 | VLS | $117.79 | $24K | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| 2 | Nov 2025 | GENERICS & SPECIALITIES LTD | Tanzania | Solution | 500 | VLS | $191.66 | $96K | MUMBAI AIR (SAHAR) | DAR ES SALAM (DARESS | AIR |
| 3 | Nov 2025 | IBL LTD | Mauritius | Solution | 110 | VLS | $257.46 | $28K | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 4 | Dec 2025 | ABACUS PHARMA (A) LTD | Uganda | Injection | 200 | VLS | $118.05 | $24K | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| SUPPLIER #2 — RELIANCE LIFE SCIENCES PVT LTD · 3 shipments · $163K | |||||||||||
| 5 | Nov 2025 | WMT PHARMACEUTICALS PVT LTD | Zimbabwe | Solution | 200 | VLS | $119.87 | $24K | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 6 | Nov 2025 | STAR BIOTECH LTD | Rwanda | Solution | 100 | VLS | $121.36 | $12K | MUMBAI AIR (SAHAR) | KIGALI - | AIR |
| 7 | Dec 2025 | GALAXY PHARMACEUTICAL LTD | Kenya | Solution | 1.3K | VLS | $101.44 | $127K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #3 — M T MADON EXPORTS · 1 shipments · $8K | |||||||||||
| 8 | Nov 2025 | MORAN PHARMACY LTD | Kenya | Injection | 100 | NOS | $76.04 | $8K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #4 — WELLKIND PHARMACEUTICAL PVT LTD · 1 shipments · $5K | |||||||||||
| 9 | Nov 2025 | NEW AFRICA SOFTWARE SOLUTION LTD | Ghana | Injection | 30 | NOS | $169.69 | $5K | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #5 — KHATU ENTERPRISES · 2 shipments · $691.15 | |||||||||||
| 10 | Dec 2025 | HORIZON PHARMACEUTICAL COMPANY | Somalia | Injection | 8 | NOS | $69.11 | $552.92 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 11 | Dec 2025 | HORIZON PHARMACEUTICAL COMPANY | Somalia | Injection | 2 | NOS | $69.11 | $138.23 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
8 countries · 19 shipments · $3.81M · 4 Indian suppliers · 10 buyers
SHIPMENTS
19
USD
$3.81M
COUNTRIES
8
SUPPLIERS
4
BUYERS
10
HHI
8,976
concentrated
Top 8 destination countries in Asia
1
Sri Lanka (57.1%)
$2.18M
2
Philippines (22.6%)
$861K
3
Lebanon (14.3%)
$545K
4
Vietnam (3.6%)
$138K
5
Bahrain (2.3%)
$89K
6
Nepal (0.0%)
$145.09
7
Maldives (0.0%)
$8.51
8
Myanmar · Myanmar
$0.0000
Top 4 Indian suppliers into Asia
1
RELIANCE LIFE SCIENCES PVT LTD
$3.60M
2
BHARAT SERUMS AND VACCINES LTD
$206K
3
CHARAK PHARMA PVT LTD
$145.09
4
MEDICARE PHARMA
$8.51
Top 10 Asia importers
1
STATE PHARMACEUTICALS CORP · Sri Lanka
$2.16M
2
AMBICA INTERNATIONAL CORP · Philippines
$655K
3
LEVANT PULSE · Lebanon
$545K
4
BSV BIOSCIENCE PHILIPPINES INC · Philippines
$206K
5
DUY ANH TRADING PHARMACY COMPANY LI · Vietnam
$138K
6
GULF PHARMACIES W.L.L · Bahrain
$89K
7
ABC PHARMA SERVICES (PVT) LTD · Sri Lanka
$17K
8
ALPINE PHARMA.DISTT PVT LTD · Nepal
$145.09
9
TREE TOP HEALTH PVT LTD · Maldives
$8.51
10
ASIA HEALTH & WEALTH COMPANY LIMITE · Myanmar
$0.0000
Top 5 dosage forms
1
Vial
$2.16M
2
Other
$852K
3
Solution
$710K
4
Injection
$89K
5
Tablet
$8.51
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $145.09 | $145.09 |
| Nov | 14 | $3.69M | $264K |
| Dec | 4 | $115K | $29K |
Shipment register · 19 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RELIANCE LIFE SCIENCES PVT LTD · 14 shipments · $3.60M | |||||||||||
| 1 | Nov 2025 | STATE PHARMACEUTICALS CORP | Sri Lanka | Vial | 22.2K | VLS | $97.32 | $2.16M | CHENNAI AIR | COLOMBO | AIR |
| 2 | Nov 2025 | ASIA HEALTH & WEALTH COMPANY LIMITE | Myanmar | Solution | 1 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | YANGON | AIR |
| 3 | Nov 2025 | ASIA HEALTH & WEALTH COMPANY LIMITE | Myanmar | Solution | 1 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | YANGON | AIR |
| 4 | Nov 2025 | LEVANT PULSE | Lebanon | Solution | 1.5K | VLS | $129.85 | $195K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 5 | Nov 2025 | LEVANT PULSE | Lebanon | Solution | 2.7K | VLS | $129.85 | $351K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 6 | Nov 2025 | AMBICA INTERNATIONAL CORP | Philippines | Other | 1.2K | VLS | $64.57 | $79K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 7 | Nov 2025 | AMBICA INTERNATIONAL CORP | Philippines | Other | 8.8K | VLS | $64.57 | $567K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 8 | Nov 2025 | AMBICA INTERNATIONAL CORP | Philippines | Other | 1 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 9 | Nov 2025 | DUY ANH TRADING PHARMACY COMPANY LI | Vietnam | Solution | 2.1K | VLS | $66.95 | $138K | MUMBAI AIR (SAHAR) | HO CHI MINH C | AIR |
| 10 | Nov 2025 | DUY ANH TRADING PHARMACY COMPANY LI | Vietnam | Solution | 1 | VLS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | HO CHI MINH C | AIR |
| 11 | Dec 2025 | ABC PHARMA SERVICES (PVT) LTD | Sri Lanka | Solution | 100 | VLS | $173.82 | $17K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 12 | Dec 2025 | AMBICA INTERNATIONAL CORP | Philippines | Solution | 5.4K | VLS | $1.47 | $8K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 13 | Dec 2025 | AMBICA INTERNATIONAL CORP | Philippines | Solution | 625 | VLS | $1.47 | $921.73 | MUMBAI AIR (SAHAR) | MANILA | SEA |
| 14 | Dec 2025 | GULF PHARMACIES W.L.L | Bahrain | Injection | 550 | VLS | $161.45 | $89K | MUMBAI AIR (SAHAR) | BAHRAIN | AIR |
| SUPPLIER #2 — BHARAT SERUMS AND VACCINES LTD · 1 shipments · $206K | |||||||||||
| 15 | Nov 2025 | BSV BIOSCIENCE PHILIPPINES INC | Philippines | Other | 1.0K | VLS | $206.01 | $206K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| SUPPLIER #3 — CHARAK PHARMA PVT LTD · 1 shipments · $145.09 | |||||||||||
| 16 | Oct 2025 | ALPINE PHARMA.DISTT PVT LTD | Nepal | Solution | 180 | NOS | $0.806 | $145.09 | RAXAUL | Birgunj | ROAD |
| SUPPLIER #4 — MEDICARE PHARMA · 3 shipments · $8.51 | |||||||||||
| 17 | Nov 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 100 | PCS | $0.020 | $1.98 | CHENNAI AIR | MALE | AIR |
| 18 | Nov 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 40 | PCS | $0.030 | $1.19 | CHENNAI AIR | MALE | AIR |
| 19 | Nov 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 60 | PCS | $0.089 | $5.34 | CHENNAI AIR | MALE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 3 shipments · $56K · 3 Indian suppliers · 3 buyers
SHIPMENTS
3
USD
$56K
COUNTRIES
3
SUPPLIERS
3
BUYERS
3
HHI
5,176
concentrated
Top 3 destination countries in Europe
1
Italy (66.3%)
$37K
2
France (27.1%)
$15K
3
Bulgaria (6.6%)
$4K
Top 3 Indian suppliers into Europe
1
GLENMARK PHARMACEUTICALS LTD
$37K
2
BHARAT SERUMS AND VACCINES LTD
$15K
3
GOOD FAITH PHARMA IMPEX
$4K
Top 3 Europe importers
1
DIFA COOPER S.P.A · Italy
$37K
2
TEDIS · France
$15K
3
LYUDMIL STANEV · Bulgaria
$4K
Top 2 dosage forms
1
Other
$41K
2
Solution
$15K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 3 | $56K | $19K |
| Dec | 0 | $0.0000 | — |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — GLENMARK PHARMACEUTICALS LTD · 1 shipments · $37K | |||||||||||
| 1 | Nov 2025 | DIFA COOPER S.P.A | Italy | Other | 3.9K | NOS | $9.58 | $37K | MUMBAI AIR (SAHAR) | MILAN - MALPENSA | AIR |
| SUPPLIER #2 — BHARAT SERUMS AND VACCINES LTD · 1 shipments · $15K | |||||||||||
| 2 | Nov 2025 | TEDIS | France | Solution | 100 | VLS | $153.21 | $15K | MUMBAI AIR (SAHAR) | PARIS - CHARLES DE G | AIR |
| SUPPLIER #3 — GOOD FAITH PHARMA IMPEX · 1 shipments · $4K | |||||||||||
| 3 | Nov 2025 | LYUDMIL STANEV | Bulgaria | Other | 15 | NOS | $246.91 | $4K | MUMBAI AIR (SAHAR) | RALEIGH | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
3 countries · 4 shipments · $606K · 3 Indian suppliers · 3 buyers
SHIPMENTS
4
USD
$606K
COUNTRIES
3
SUPPLIERS
3
BUYERS
3
HHI
5,465
concentrated
Top 3 destination countries in Americas
1
Colombia (67.5%)
$410K
2
Nicaragua (30.0%)
$182K
3
Brazil (2.5%)
$15K
Top 3 Indian suppliers into Americas
1
RELIANCE LIFE SCIENCES PVT LTD
$410K
2
CAPLIN POINT LABORATORIES LTD
$182K
3
VAMA LIFECARE PVT LTD
$15K
Top 3 Americas importers
1
NEXT PHARMA SOURCING SAS · Colombia
$410K
2
NEOETHICALS, S.A · Nicaragua
$182K
3
AS PER INVOICE BRAZIL · Brazil
$15K
Top 1 dosage forms
1
Solution
$606K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $182K | $182K |
| Nov | 0 | $0.0000 | — |
| Dec | 3 | $425K | $142K |
Shipment register · 4 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RELIANCE LIFE SCIENCES PVT LTD · 2 shipments · $410K | |||||||||||
| 1 | Dec 2025 | NEXT PHARMA SOURCING SAS | Colombia | Solution | 3.4K | VLS | $122.24 | $410K | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| 2 | Dec 2025 | NEXT PHARMA SOURCING SAS | Colombia | Solution | 218 | VLS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| SUPPLIER #2 — CAPLIN POINT LABORATORIES LTD · 1 shipments · $182K | |||||||||||
| 3 | Oct 2025 | NEOETHICALS, S.A | Nicaragua | Solution | 2.0K | NOS | $90.80 | $182K | CHENNAI AIR | MANAGUA | AIR |
| SUPPLIER #3 — VAMA LIFECARE PVT LTD · 1 shipments · $15K | |||||||||||
| 4 | Dec 2025 | AS PER INVOICE BRAZIL | Brazil | Solution | 120 | NOS | $126.63 | $15K | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 11 Indian immunoglobulin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped immunoglobulin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PVT LTD | NAVI MUMBAI MAHARASHTRA | 19 | $4.17M | Solution, Vial, Other | Africa, Asia |
| 2 | BHARAT SERUMS AND VACCINES LTD | AIROLI NAVI MUMBAI | 6 | $393K | Other, Solution, Injection | Asia, Africa |
| 3 | CAPLIN POINT LABORATORIES LTD | TIRUVALLUR DIST | 1 | $182K | Solution | Americas |
| 4 | GLENMARK PHARMACEUTICALS LTD | GOA | 1 | $37K | Other | Europe |
| 5 | VAMA LIFECARE PVT LTD | MUMBAI | 1 | $15K | Solution | Americas |
| 6 | M T MADON EXPORTS | MUMBAI | 1 | $8K | Injection | Africa |
| 7 | WELLKIND PHARMACEUTICAL PVT LTD | MUZAFFARANAGAR | 1 | $5K | Injection | Africa |
| 8 | GOOD FAITH PHARMA IMPEX | Nagpur | 1 | $4K | Other | Europe |
| 9 | KHATU ENTERPRISES | NAGPUR | 2 | $691.15 | Injection | Africa |
| 10 | CHARAK PHARMA PVT LTD | GHAZIABAD (U.P.) | 1 | $145.09 | Solution | Asia |
| 11 | MEDICARE PHARMA | CHENNAI | 3 | $8.51 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 25 global immunoglobulin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian immunoglobulin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | STATE PHARMACEUTICALS CORP | Sri Lanka | 1 | $2.16M | RELIANCE LIFE SCIENC… | Vial |
| 2 | AMBICA INTERNATIONAL CORP | Philippines | 5 | $655K | RELIANCE LIFE SCIENC… | Other, Solution |
| 3 | LEVANT PULSE | Lebanon | 2 | $545K | RELIANCE LIFE SCIENC… | Solution |
| 4 | NEXT PHARMA SOURCING SAS | Colombia | 2 | $410K | RELIANCE LIFE SCIENC… | Solution |
| 5 | BSV BIOSCIENCE PHILIPPINES INC | Philippines | 1 | $206K | BHARAT SERUMS AND VA… | Other |
| 6 | NEOETHICALS, S.A | Nicaragua | 1 | $182K | CAPLIN POINT LABORAT… | Solution |
| 7 | DUY ANH TRADING PHARMACY COMPANY LI | Vietnam | 2 | $138K | RELIANCE LIFE SCIENC… | Solution |
| 8 | GALAXY PHARMACEUTICAL LTD | Kenya | 1 | $127K | RELIANCE LIFE SCIENC… | Solution |
| 9 | GENERICS & SPECIALITIES LTD | Tanzania | 1 | $96K | BHARAT SERUMS AND VA… | Solution |
| 10 | GULF PHARMACIES W.L.L | Bahrain | 1 | $89K | RELIANCE LIFE SCIENC… | Injection |
| 11 | ABACUS PHARMA (A) LTD | Uganda | 2 | $47K | BHARAT SERUMS AND VA… | Solution, Injection |
| 12 | DIFA COOPER S.P.A | Italy | 1 | $37K | GLENMARK PHARMACEUTI… | Other |
| 13 | IBL LTD | Mauritius | 1 | $28K | BHARAT SERUMS AND VA… | Solution |
| 14 | WMT PHARMACEUTICALS PVT LTD | Zimbabwe | 1 | $24K | RELIANCE LIFE SCIENC… | Solution |
| 15 | ABC PHARMA SERVICES (PVT) LTD | Sri Lanka | 1 | $17K | RELIANCE LIFE SCIENC… | Solution |
| 16 | TEDIS | France | 1 | $15K | BHARAT SERUMS AND VA… | Solution |
| 17 | AS PER INVOICE BRAZIL | Brazil | 1 | $15K | VAMA LIFECARE PVT LTD | Solution |
| 18 | STAR BIOTECH LTD | Rwanda | 1 | $12K | RELIANCE LIFE SCIENC… | Solution |
| 19 | MORAN PHARMACY LTD | Kenya | 1 | $8K | M T MADON EXPORTS | Injection |
| 20 | NEW AFRICA SOFTWARE SOLUTION LTD | Ghana | 1 | $5K | WELLKIND PHARMACEUTI… | Injection |
| 21 | LYUDMIL STANEV | Bulgaria | 1 | $4K | GOOD FAITH PHARMA IM… | Other |
| 22 | HORIZON PHARMACEUTICAL COMPANY | Somalia | 2 | $691.15 | KHATU ENTERPRISES | Injection |
| 23 | ALPINE PHARMA.DISTT PVT LTD | Nepal | 1 | $145.09 | CHARAK PHARMA PVT LTD | Solution |
| 24 | TREE TOP HEALTH PVT LTD | Maldives | 3 | $8.51 | MEDICARE PHARMA | Tablet |
| 25 | ASIA HEALTH & WEALTH COMPANY LIMITE | Myanmar | 2 | $0.0000 | RELIANCE LIFE SCIENC… | Solution |
This report covers 37 2025-Q4 Immunoglobulin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/immunoglobulin
Talk to our trade analyst
Need a custom immunoglobulin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/immunoglobulin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Immunoglobulin product page
Live data, supplier directory, price trends, and trade route analysis